Skip to main content

Table 1 The relationship between miR-29a-3p expression in EC tissues and clinicopathological characteristics of patients

From: miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1

Characteristics

Number(n = 72)

Relative miR-29a-3p expression

P value

Age (years)

  

0.2910

  < 50

36

0.533 ± 0.107

 

  ≥ 50

36

0.504 ± 0.132

 

Differentiation

  

0.001**

 High and mediumdifferentiation

31

0.587 ± 0.106

 

 Low and undifferentiation

41

0.467 ± 0.102

 

FIGO stage

  

< 0.0001 ***

 I-II

43

0.566 ± 0.098

 

 III-IV

29

0.448 ± 0.116

 

Cancer type

  

0.9093

 Type I

24

0.516 ± 0.131

 

 Type II

48

0.520 ± 0.116

 

Muscular infiltration

  

0.0002 ***

  < 1/2

34

0.572 ± 0.103

 

  ≥ 1/2

38

0.471 ± 0.115

 

Lymphatic metastasis

  

< 0.0001 ***

 No

28

0.548 ± 0.124

 

 Yes

44

0.423 ± 0.115

 
  1. **P < 0.01 and ***P < 0.001. Note: Type I indicated patientswithestrogen receptor-dependent EC. Type II indicated patients with non-estrogen receptor-dependent EC
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us